{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"columns":[{"gene":"","key":"MONDO:0011503/OMIM:604931","label":"Cortisone reductase deficiency 1","mondoId":"MONDO:0011503","onsetQualifier":null,"recordKeys":["244ba6474d63c60eb672f3080f9ac7f9e5f36d620bbdc735b61efac2693f06d5","25ac361226f819507cbe3c2fef6a6f470842329623d05d5c6430046e8f92fefe","35a5747268f74218e8babd62156e065c9c9f9d600040925f1cbdb038632a95de","88afd306a8873e87a356170152d6f44c1bcd7fd05e3356c2b64f6ecdf06a373c","a2c20dff9cc1cd48a32cb4d9d4aa4dee9daa1d485478f3ba4709c7c7d677443f","a95935d5a613bf23ff2167635fb84aa09f7ccc5df974fbaea7ecb2f378e2649e","cd329308b0ba0925bc4d8b9648f2611b6f8d8eefa57ad21cd2d418cec0f82823"],"recordQualifiers":{},"scopeLabel":"OMIM:604931","sourceIds":["OMIM:604931"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."},{"gene":"","key":"MONDO:0013842/OMIM:614662","label":"Cortisone reductase deficiency 2","mondoId":"MONDO:0013842","onsetQualifier":null,"recordKeys":["01c0b8f5371e4aab28999060a061184addc73078ae62865567201e60332402d9","311d4e5d5b281cb649ab9db9e3c3fbf8b3bf94d3d65e84a89c5c9345a02100b5","7473165cf2ad2cfdcfb951816dbf6562d128c0a821988d453eefff7030b4eb03","894143847b97d0d3eb1bc0322a7a43cf39a09f437fc20ff24f0c494f75c48178","96c8abbfe6519d91ea247d3d44a09a490e0162cc830f19fea636f9c838fd68df","ccfc03bc2978cc2b4abc85da1816309675363472adfba11c525c6525c7898bc6","f8ad6b7602bf8a341c39f5f07d6cfa47916ff886c11eba1552b2400321362cc6"],"recordQualifiers":{},"scopeLabel":"OMIM:614662","sourceIds":["OMIM:614662"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."},{"gene":"","key":"MONDO:0000193/ORPHA:168588","label":"Hyperandrogenism due to cortisone reductase deficiency","mondoId":"MONDO:0000193","onsetQualifier":null,"recordKeys":["258779da7ad8872b69d6c2c147e87780cef2b6beebad9ef3721544b24c62f15e","405bfc09e10b5d62d3098a15fa46b7afa8c3623faa9e607c6ddedf1928236057","42b25efdcf986bfbcb02bd1fa5a41cdbb257247901c79d1b22b0d7f83f84fc0b","4fcfb45d7d1a51ef56b1c27680ede1acc14de8cd00ef14be2bdd713a69d0f340","5a9b7aecdf8cfa6d2e693d160e1046d4bce600c75bae8c0a246f85a76139709f","5ac1f6dcbfcdbffbd4485d8b994cbd588f4c9f96e590cf6b3c27710856c65547","6bd488aa500e76b47587c01eabb88d3d94b39405b4213de3f3733cd64cfa3f6e","6c30fc6193766fb217e1036b6272c2d2b4e3427718d703e1ceeccef6fe58ce2b","d30b71ee676db65ab1cc21211965f585489ae94f354676ef8624eaa4b631a61f","daa73aa7038fa6771af9bacba686cb105e2908dc18cde76e396251b392e365f2"],"recordQualifiers":{},"scopeLabel":"ORPHA:168588","sourceIds":["ORPHA:168588"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"comparison":{"collapseColumnsLabel":"Show initial comparisons","defaultColumnKeys":["MONDO:0011503/OMIM:604931","MONDO:0013842/OMIM:614662","MONDO:0000193/ORPHA:168588"],"expandColumnsLabel":"Compare all source entries","intro":"Compare the original source entries. Different entries may describe different patient groups.","primaryFeatureIds":[],"scopeNoteHtml":"<p>Each column keeps its native condition scope. Initial features are displayed alphabetically, not ranked by clinical importance. Counts remain separate, and an empty cell does not mean a feature cannot occur.</p>"},"coverage":{"countRecords":13,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":24,"sourceGroups":{"omim":1,"orphanet":10,"published":13}},"features":[{"hpoId":"HP:0031186","label":"Abnormal circulating deoxycorticosterone level","primary":false},{"hpoId":"HP:0000956","label":"Acanthosis nigricans","primary":false},{"hpoId":"HP:0005616","label":"Accelerated skeletal maturation","primary":false},{"hpoId":"HP:0001061","label":"Acne","primary":false},{"hpoId":"HP:0001596","label":"Alopecia","primary":false},{"hpoId":"HP:0008258","label":"Congenital adrenal hyperplasia","primary":false},{"hpoId":"HP:0003351","label":"Decreased circulating renin concentration","primary":false},{"hpoId":"HP:0025436","label":"Elevated serum 11-deoxycortisol","primary":false},{"hpoId":"HP:0001007","label":"Hirsutism","primary":false},{"hpoId":"HP:0000822","label":"Hypertension","primary":false},{"hpoId":"HP:0002900","label":"Hypokalemia","primary":false},{"hpoId":"HP:0030348","label":"Increased circulating androgen concentration","primary":false},{"hpoId":"HP:0000789","label":"Infertility","primary":false},{"hpoId":"HP:0000855","label":"Insulin resistance","primary":false},{"hpoId":"HP:0000858","label":"Irregular menstruation","primary":false},{"hpoId":"HP:6000185","label":"Low tetrahydrocortisol (THF) plus 5-alpha-THF/tetrahydrocortisone (THE) ratio","primary":false},{"hpoId":"HP:0001513","label":"Obesity","primary":false},{"hpoId":"HP:0000876","label":"Oligomenorrhea","primary":false},{"hpoId":"HP:0000826","label":"Precocious puberty","primary":false},{"hpoId":"HP:0012412","label":"Premature adrenarche","primary":false},{"hpoId":"HP:0012411","label":"Premature pubarche","primary":false},{"hpoId":"HP:6001080","label":"Reduced urine tetrahydrocortisol plus 5-alpha-THF to tetrahydrocortisone ratio","primary":false}],"ledeHtml":"A patient-friendly description is not yet available in the ingested narrative sources for this condition.","mondoId":"MONDO:0000193","records":[{"frequencyKind":"count","key":"01c0b8f5371e4aab28999060a061184addc73078ae62865567201e60332402d9","raw":{"aspect":"P","body_system":"endocrine","disease_id":"OMIM:614662","disease_name":"Cortisone reductase deficiency 2","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:6000185","is_excluded":false,"label":"Low tetrahydrocortisol (THF) plus 5-alpha-THF/tetrahydrocortisone (THE) ratio","onset_id":null,"reference":"PMID:21325058","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"244ba6474d63c60eb672f3080f9ac7f9e5f36d620bbdc735b61efac2693f06d5","raw":{"aspect":"P","body_system":"skin","disease_id":"OMIM:604931","disease_name":"Cortisone reductase deficiency 1","evidence":"PCS","frequency_raw":"3/4","hpo_id":"HP:0001007","is_excluded":false,"label":"Hirsutism","onset_id":null,"reference":"PMID:18628520","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"258779da7ad8872b69d6c2c147e87780cef2b6beebad9ef3721544b24c62f15e","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:168588","disease_name":"Hyperandrogenism due to cortisone reductase deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000822","is_excluded":false,"label":"Hypertension","onset_id":null,"reference":"ORPHA:168588","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"25ac361226f819507cbe3c2fef6a6f470842329623d05d5c6430046e8f92fefe","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"OMIM:604931","disease_name":"Cortisone reductase deficiency 1","evidence":"PCS","frequency_raw":"2/3","hpo_id":"HP:0000789","is_excluded":false,"label":"Infertility","onset_id":null,"reference":"PMID:18628520","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"311d4e5d5b281cb649ab9db9e3c3fbf8b3bf94d3d65e84a89c5c9345a02100b5","raw":{"aspect":"P","body_system":"growth","disease_id":"OMIM:614662","disease_name":"Cortisone reductase deficiency 2","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0001513","is_excluded":false,"label":"Obesity","onset_id":null,"reference":"PMID:21325058","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"35a5747268f74218e8babd62156e065c9c9f9d600040925f1cbdb038632a95de","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"OMIM:604931","disease_name":"Cortisone reductase deficiency 1","evidence":"PCS","frequency_raw":"1/3","hpo_id":"HP:0000876","is_excluded":false,"label":"Oligomenorrhea","onset_id":null,"reference":"PMID:18628520","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"405bfc09e10b5d62d3098a15fa46b7afa8c3623faa9e607c6ddedf1928236057","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:168588","disease_name":"Hyperandrogenism due to cortisone reductase deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002900","is_excluded":false,"label":"Hypokalemia","onset_id":null,"reference":"ORPHA:168588","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"42b25efdcf986bfbcb02bd1fa5a41cdbb257247901c79d1b22b0d7f83f84fc0b","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:168588","disease_name":"Hyperandrogenism due to cortisone reductase deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000826","is_excluded":false,"label":"Precocious puberty","onset_id":null,"reference":"ORPHA:168588","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"4fcfb45d7d1a51ef56b1c27680ede1acc14de8cd00ef14be2bdd713a69d0f340","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:168588","disease_name":"Hyperandrogenism due to cortisone reductase deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0030348","is_excluded":false,"label":"Increased circulating androgen concentration","onset_id":null,"reference":"ORPHA:168588","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"5a9b7aecdf8cfa6d2e693d160e1046d4bce600c75bae8c0a246f85a76139709f","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:168588","disease_name":"Hyperandrogenism due to cortisone reductase deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0031186","is_excluded":false,"label":"Abnormal circulating deoxycorticosterone level","onset_id":null,"reference":"ORPHA:168588","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"5ac1f6dcbfcdbffbd4485d8b994cbd588f4c9f96e590cf6b3c27710856c65547","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:168588","disease_name":"Hyperandrogenism due to cortisone reductase deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0012412","is_excluded":false,"label":"Premature adrenarche","onset_id":null,"reference":"ORPHA:168588","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"6bd488aa500e76b47587c01eabb88d3d94b39405b4213de3f3733cd64cfa3f6e","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:168588","disease_name":"Hyperandrogenism due to cortisone reductase deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000858","is_excluded":false,"label":"Irregular menstruation","onset_id":null,"reference":"ORPHA:168588","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"6c30fc6193766fb217e1036b6272c2d2b4e3427718d703e1ceeccef6fe58ce2b","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:168588","disease_name":"Hyperandrogenism due to cortisone reductase deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0025436","is_excluded":false,"label":"Elevated serum 11-deoxycortisol","onset_id":null,"reference":"ORPHA:168588","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"7473165cf2ad2cfdcfb951816dbf6562d128c0a821988d453eefff7030b4eb03","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:614662","disease_name":"Cortisone reductase deficiency 2","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0005616","is_excluded":false,"label":"Accelerated skeletal maturation","onset_id":null,"reference":"PMID:21325058","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"88afd306a8873e87a356170152d6f44c1bcd7fd05e3356c2b64f6ecdf06a373c","raw":{"aspect":"P","body_system":"endocrine","disease_id":"OMIM:604931","disease_name":"Cortisone reductase deficiency 1","evidence":"PCS","frequency_raw":"1/4","hpo_id":"HP:0000826","is_excluded":false,"label":"Precocious puberty","onset_id":null,"reference":"PMID:18628520","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"894143847b97d0d3eb1bc0322a7a43cf39a09f437fc20ff24f0c494f75c48178","raw":{"aspect":"P","body_system":"skin","disease_id":"OMIM:614662","disease_name":"Cortisone reductase deficiency 2","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0000956","is_excluded":false,"label":"Acanthosis nigricans","onset_id":null,"reference":"PMID:21325058","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"96c8abbfe6519d91ea247d3d44a09a490e0162cc830f19fea636f9c838fd68df","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:614662","disease_name":"Cortisone reductase deficiency 2","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0000855","is_excluded":false,"label":"Insulin resistance","onset_id":null,"reference":"PMID:21325058","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"a2c20dff9cc1cd48a32cb4d9d4aa4dee9daa1d485478f3ba4709c7c7d677443f","raw":{"aspect":"P","body_system":"growth","disease_id":"OMIM:604931","disease_name":"Cortisone reductase deficiency 1","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001513","is_excluded":false,"label":"Obesity","onset_id":null,"reference":"OMIM:604931","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"a95935d5a613bf23ff2167635fb84aa09f7ccc5df974fbaea7ecb2f378e2649e","raw":{"aspect":"P","body_system":"skin","disease_id":"OMIM:604931","disease_name":"Cortisone reductase deficiency 1","evidence":"PCS","frequency_raw":"1/4","hpo_id":"HP:0001061","is_excluded":false,"label":"Acne","onset_id":null,"reference":"PMID:18628520","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"ccfc03bc2978cc2b4abc85da1816309675363472adfba11c525c6525c7898bc6","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:614662","disease_name":"Cortisone reductase deficiency 2","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:6001080","is_excluded":false,"label":"Reduced urine tetrahydrocortisol plus 5-alpha-THF to tetrahydrocortisone ratio","onset_id":null,"reference":"PMID:21325058","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"cd329308b0ba0925bc4d8b9648f2611b6f8d8eefa57ad21cd2d418cec0f82823","raw":{"aspect":"P","body_system":"skin","disease_id":"OMIM:604931","disease_name":"Cortisone reductase deficiency 1","evidence":"PCS","frequency_raw":"1/4","hpo_id":"HP:0001596","is_excluded":false,"label":"Alopecia","onset_id":null,"reference":"PMID:18628520","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"d30b71ee676db65ab1cc21211965f585489ae94f354676ef8624eaa4b631a61f","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:168588","disease_name":"Hyperandrogenism due to cortisone reductase deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0003351","is_excluded":false,"label":"Decreased circulating renin concentration","onset_id":null,"reference":"ORPHA:168588","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"daa73aa7038fa6771af9bacba686cb105e2908dc18cde76e396251b392e365f2","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:168588","disease_name":"Hyperandrogenism due to cortisone reductase deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0008258","is_excluded":false,"label":"Congenital adrenal hyperplasia","onset_id":null,"reference":"ORPHA:168588","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"f8ad6b7602bf8a341c39f5f07d6cfa47916ff886c11eba1552b2400321362cc6","raw":{"aspect":"P","body_system":"endocrine","disease_id":"OMIM:614662","disease_name":"Cortisone reductase deficiency 2","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0012411","is_excluded":false,"label":"Premature pubarche","onset_id":null,"reference":"PMID:21325058","source_release":"2026-06-23"},"sourceGroups":["published"]}],"referenceLabels":{},"references":{"causeHtml":"<p>No mapped MedlinePlus condition document in this snapshot.</p>","identityNote":"MONDO defines condition identity and route membership. Native evidence populations and narrative coverage retain their separate scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>No MedlinePlus narrative has been mapped to this MONDO condition. Feature annotations, when available, are retained below.</p>","key":"overview","title":"Condition overview"}],"sharedSources":[],"slug":"cortisone-reductase-deficiency","sourceDocuments":[],"sourceNote":"MONDO condition identity; scoped MedlinePlus enrichment where available; original HPO annotations.","takeawayHtml":"Cause information is not available in the mapped narrative sources for this condition.","title":"cortisone reductase deficiency"},"schemaVersion":1}